The paradigm of molecular histopathology is shifting from a single-marker immunohistochemistry towards multiplexed detection of markers to better understand the complex pathological processes. However, there are no systems allowing multiplexed IHC (mIHC) with high-resolution whole-slide tissue imaging and analysis, yet providing feasible throughput for routine use. We present an mIHC platform combining fluorescent and chromogenic staining with automated whole-slide imaging and integrated whole-slide image analysis, enabling simultaneous detection of six protein markers and nuclei, and automatic quantification and classification of hundreds of thousands of cells in situ in formalin-fixed paraffin-embedded tissues. In the first proof-of-conce...
Traditional immunohistochemistry (IHC) is inherently limited by its ability to analyze only several ...
Biomarkers play a key role in risk assessment, assessing treatment response, and detecting recurrenc...
The TSA Opal multiplex immunohistochemistry (mIHC) protocol (PerkinElmer) has been used to character...
Background: Successful digital image analysis (DIA) of cancer tissue is accurate and reproducible. T...
Disease states and cellular compartments can display a remarkable amount of heterogeneity, and truly...
Background: Multiplex tissue analysis has revolutionized our understanding of the tumor microenviron...
Technological breakthroughs have fundamentally changed our understanding on the complexity of the tu...
Limitations on the number of unique protein and DNA molecules that can be characterized microscopica...
Progress in cancer research is substantially dependent on innovative technologies that permit a conc...
Multiplex immunofluorescence is a powerful tool for the simultaneous detection of tissue‐based bioma...
Multiplexed platforms for multiple epitope detection have emerged in the last years as very powerful...
Because of the close interaction between tumors and the immune system, immunotherapies are nowadays ...
An array of phenotypically diverse myeloid cells and macrophages (MC&M) resides in the tumor mic...
Objectives The interaction between the immune system and tumor cells is an important feature for the...
Immune checkpoint inhibitors, including those concerning programmed cell death 1 (PD-1) and its liga...
Traditional immunohistochemistry (IHC) is inherently limited by its ability to analyze only several ...
Biomarkers play a key role in risk assessment, assessing treatment response, and detecting recurrenc...
The TSA Opal multiplex immunohistochemistry (mIHC) protocol (PerkinElmer) has been used to character...
Background: Successful digital image analysis (DIA) of cancer tissue is accurate and reproducible. T...
Disease states and cellular compartments can display a remarkable amount of heterogeneity, and truly...
Background: Multiplex tissue analysis has revolutionized our understanding of the tumor microenviron...
Technological breakthroughs have fundamentally changed our understanding on the complexity of the tu...
Limitations on the number of unique protein and DNA molecules that can be characterized microscopica...
Progress in cancer research is substantially dependent on innovative technologies that permit a conc...
Multiplex immunofluorescence is a powerful tool for the simultaneous detection of tissue‐based bioma...
Multiplexed platforms for multiple epitope detection have emerged in the last years as very powerful...
Because of the close interaction between tumors and the immune system, immunotherapies are nowadays ...
An array of phenotypically diverse myeloid cells and macrophages (MC&M) resides in the tumor mic...
Objectives The interaction between the immune system and tumor cells is an important feature for the...
Immune checkpoint inhibitors, including those concerning programmed cell death 1 (PD-1) and its liga...
Traditional immunohistochemistry (IHC) is inherently limited by its ability to analyze only several ...
Biomarkers play a key role in risk assessment, assessing treatment response, and detecting recurrenc...
The TSA Opal multiplex immunohistochemistry (mIHC) protocol (PerkinElmer) has been used to character...